Suven Pharma Q3 Results: Net profit surges 78% to Rs 83 crore, revenue up 40%
PE firm Advent backed Suven Pharma net profit rose 78% year-on-year (YoY) to Rs 83.3 crore in Q3FY25 compared to Rs 46.8 crore in the corresponding period of the previous year. Revenue grew 40% YoY to Rs 307.2 crore in Q3FY25 driven by doubling of CDMO business driven by R&D and business development efforts. Gross…